EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Delivering Drugs to Tubular Cells and Organelles: The Application of Nanodrugs in Acute Kidney Injury

Zhi Li, Xiao Fan, Jialong Fan, Wei Zhang, Jun Liu, Bin Liu, Hao Zhang iD

Nanomedicine · 2023

DOI: 10.2217/nnm-2023-0200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomedicine, 2023. Verfasst von Zhi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: The Scientific Research Project of Health Commission Hunan, Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a common clinical syndrome with limited treatment options and high mortality rates. Proximal tubular epithelial cells (PTECs) play a key role in AKI progression. Subcellular dysfunctions, including mitochondrial, nuclear, endoplasmic reticulum and lysosomal dysfunctions, are extensively studied in PTECs. These studies have led to the development of potential therapeutic drugs. However, clinical development of those drugs faces challenges such as low solubility, short circulation time and severe systemic side effects. Nanotechnology provides a promising solution by improving drug properties through nanocrystallization and enabling targeted delivery to specific sites. This review summarizes advancements and limitations of nanoparticle-based drug-delivery systems in targeting PTECs and subcellular organelles, particularly mitochondria, for AKI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryNanoparticlesHumansPharmaceutical PreparationsKidney Tubules, ProximalMitochondriaEpithelial CellsKidney

Stichwörter der Autor:innen

acute kidney injurymitochondrialnanoparticle-based drug-delivery systemproximal tubular epithelial cellssubcellular organelles

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
  • The Critical Kidney Disease Research Center of Central South University, Changsha, 410013, China.
  • College of Biology, Hunan University, Changsha, 410082, China.
  • Department of Physiology & Pathophysiology, NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, 750004, China.

ORCID-Profile: Hao Zhang

Förderung

  • The Scientific Research Project of Health Commission Hunan
  • Hunan Province

Zitieren

APA

Li, Z., Fan, X., Fan, J., Zhang, W., Liu, J., Liu, B., & Zhang, H. (2023). Delivering Drugs to Tubular Cells and Organelles: The Application of Nanodrugs in Acute Kidney Injury. Nanomedicine. https://doi.org/10.2217/nnm-2023-0200

Vancouver

Li Z, Fan X, Fan J, Zhang W, Liu J, Liu B, et al. Delivering Drugs to Tubular Cells and Organelles: The Application of Nanodrugs in Acute Kidney Injury. Nanomedicine. 2023. doi:10.2217/nnm-2023-0200

BibTeX
@article{Li2023,
  author = {Li, Zhi and Fan, Xiao and Fan, Jialong and Zhang, Wei and Liu, Jun and Liu, Bin and Zhang, Hao},
  title = {Delivering Drugs to Tubular Cells and Organelles: The Application of Nanodrugs in Acute Kidney Injury},
  journal = {Nanomedicine},
  year = {2023},
  doi = {10.2217/nnm-2023-0200}
}
Kostenlos starten →